| 摘要 |
Provided herein are medicinal compositions of matter that comprise an HMG CoA reductase inhibitor medication component and a CoEnzyme Q-10 component. Through use of the compositions of the invention a reduction of potential adverse physiologic effects is observed in the treatment of hypercholesterolemia, mixed dyslipidemia, and coronary artery disease. The invention also provides procedures for administering the composition to a patient who is afflicted with hypercholesterolemia, mixed dyslipidemia, or coronary artery disease.
|
